Immunotherapy Reaches New Heights in Upper GI Cancer Trials

Immunotherapy has demonstrated significant benefits in recent large trials, reaching new survival benchmarks for upper gastrointestinal cancers across various settings of disease, according to Jaffer A. Ajani, MD.

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *